Nintedanib in rheumatoid arthritis related interstitial lung disease: real-world safety profile and risk of side effects and discontinuation.
Sebastiani M, Lepri G, Iannone C, Cassione EB, Guggino G, Lo Monaco A, Foti R, Fornaro M, Chimenti MS, Fassio A, Truglia S, Cozzini F, Carletto A, Giollo A, Corrado A, Bazzani C, Guiducci S, Favalli E, Bugatti S, Iannone F, Caporali R, Manfredi A.
Sebastiani M, et al.
J Rheumatol. 2024 Dec 15:jrheum.2024-0976. doi: 10.3899/jrheum.2024-0976. Online ahead of print.
J Rheumatol. 2024.
PMID: 39681380